Navigation Links
New Compound Offers Hope In Liver Cancer Treatment

The identification of a novel compound, CDDO-Im, shown to possess strong anti-tumor properties in studies conducted on animal models could soon revolutionize the treatment of liver cancer patients. // The compound has been found to increase the intrinsic resistance to carcinogens (cancer causing substances) by enhancing the function of enzymes that remove toxins from the body. Further results about the compound have been published in the journal Cancer Research.

The compound has been found to be active (100 times effective than other anti-tumor compounds) at very small doses. It is hoped that the compound could play an important role in the prevention of cancers associated with inflammation such as lung cancer, liver cancer, prostate cancer and gastric cancer. It can also help in the treatment of asthma, emphysema or other neurodegenerative disorders, linked to inflammation.

The synthetic compound, a derivative of oleanolic acid, belongs to a class of compounds commonly referred to as triterpenoids. Previous studies have established the anti-tumor properties of oleanolic derivatives in animals and humans.

In order to assess the effectiveness of cancer prevention, the researchers treated rats with aflatoxin, a carcinogen, known to cause liver cancer. The rates were treated with 0.1, 0.3, 1.0, 3.0 or 10 micromole doses of CDDO-Im. As much as 85% reduction in the incidence of pre-cancerous lesions could be observed when rats were treated with 0.1 mmol of the compound. This anti-cancer property could be due to associated activation of Nrf2 protein. This protein is believed to play a major role in the protection of body against environmental toxins.

The results of this study have several important clinical applications. First, it could lead to the development of new cancer prevention strategies. Second, it can attenuate the clinical features and provide relief to those suffering from inflammatory diseases. Third, it can pro tect humans from several diseases that can be attributed to a specific environmental agent.


Related medicine news :

1. Compound of Broccoli combats breast cancer
2. New Compound Could Strengthen The Effect Of Chemotherapy
3. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
4. Compound from cottonseed for neck and head cancers
5. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
6. Adding Sorghum Compounds To Dietary Supplements May Help Lower Cholesterol
7. Compound In Grapes And Red Wine To Counter Alzheimers Disease
8. Sugars Could Contain Key Cancer Inhibiting Compounds
9. Compound From Cyanobacterium Can Fight Alzheimer’
10. Five New Anti-Inflammatory Compounds Produced By Indian Scientists
11. Compounds in Licorice Can Fight Tooth Decay
Post Your Comments:

(Date:11/29/2015)... ... November 30, 2015 , ... The Cyber Monday deal is a deep 40% or more ... time to get gifts for the skin care lover in your circle. Each Christmas, ... . This year, the 3 serums are staples: Collagen, Retinol and Hyaluronic Serums. , Stocking ...
(Date:11/29/2015)... ... November 29, 2015 , ... ProStatic Analog Distortion from ... designed specially for Final Cut Pro X. FCPX users can now ... modification controls. Destoying and creating chaotic distortion is now quick and simple, putting ...
(Date:11/28/2015)... ... November 28, 2015 , ... Trying to relax on a couch can actually ... conceived of this design due to personal experience with a bad back," he said. ... and convenience, as well as increases support. It also makes it easier to eat, ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... the University of Toronto and the University of British Columbia suggested that laws requiring ... injuries. The article explains that part of the reason for the controversial conclusion is ...
(Date:11/27/2015)... ... 27, 2015 , ... "When I was traveling, I was ... N.J. "Many people catch diseases simply from sitting on such dirty toilet seats. ... from germs." , He developed the patent-pending QUDRATECS to eliminate the need to ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 --> ... to use SyMRI to find optimal contrast weighting of MRI ... metastases, and has signed a research agreement with SyntheticMR in ... hospital. Using SyMRI, it is possible to generate multiple contrast ... after the patient has left, thus making it possible to ...
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Japanese Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
(Date:11/26/2015)... 26, 2015 ... "2016 Future Horizons and Growth Strategies ... Market: Supplier Shares, Country Segment Forecasts, Competitive ... offering. --> ) has ... Future Horizons and Growth Strategies in the ...
Breaking Medicine Technology: